We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
| Name | Symbol | Market | Type |
|---|---|---|---|
| BioNTech SE | NASDAQ:BNTX | NASDAQ | Depository Receipt |
| Price Change | % Change | Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.30 | 0.33% | 92.54 | 92.53 | 92.60 | 93.54 | 91.60 | 93.42 | 426,881 | 19:58:11 |
From May 2019 to May 2024
By Josh Beckerman
Pfizer Inc. and BioNTech SE reached an advance purchase agreement for up to 40 million Covid-19 vaccine doses with the Covax worldwide vaccination initiative.
The companies said doses will be delivered throughout 2021. The first doses are expected to be delivered in the first quarter, subject to negotiation and execution of supply agreements.
For the Covax Advance Market Commitment's 92 countries, Pfizer and BioNTech will provide the vaccine to Covax at a not-for-profit price.
Write to Josh Beckerman at josh.beckerman@wsj.com
(END) Dow Jones Newswires
January 22, 2021 12:32 ET (17:32 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.
1 Year BioNTech Chart |
1 Month BioNTech Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
